Matthew W. Davis serves as Executive at Aquestive Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Matthew W. Davis has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 10, 2025 involved receiving (via award) 50,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Nov 10, 2025 | AQST | $0 | Award | 50,000 | $N/A | Discretionary |
Matthew W. Davis currently holds 50,000 shares of Aquestive Therapeutics, Inc. (AQST), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew W. Davis has been a net neutral trader of AQST stock. They have purchased $0 and sold $0 worth of shares.
Matthew W. Davis's most recent insider trade was on Nov 10, 2025, when they sold 50,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted